MedPath

CPS Technologies Corporation Announces Phase II Award from the Department of Energy

CPS Technologies awarded $1.1M Phase II SBIR contract by U.S. DOE for 'Modular Radiation Shielding for Transportation and Use of Microreactors', led by materials scientist Matthew Karnick. CPS aims to optimize and commercialize lightweight shielding developed in Phase I, with Curtiss-Wright Nuclear as a subcontractor for radiation testing.


Reference News

CPS Technologies Corporation Announces Phase II Award from the Department of Energy

CPS Technologies awarded $1.1M Phase II SBIR contract by U.S. DOE for 'Modular Radiation Shielding for Transportation and Use of Microreactors', led by materials scientist Matthew Karnick. CPS aims to optimize and commercialize lightweight shielding developed in Phase I, with Curtiss-Wright Nuclear as a subcontractor for radiation testing.

CPS Technologies Corporation Announces Phase II Award from the Department of Energy

CPS Technologies awarded $1.1 million Phase II SBIR contract from U.S. Department of Energy for 'Modular Radiation Shielding for Transportation and Use of Microreactors'. This is CPS's second Phase II SBIR award in 2024, totaling over $3 million in recent SBIR funding. The project, led by Matthew Karnick, aims to optimize materials and scale manufacturing for commercialization, building on Phase I's successful lightweight, modular shielding development.

CPS Technologies Corporation Announces Phase II Award from the Department of Energy

CPS Technologies Corp. received a $1.1 million Phase II SBIR contract from the U.S. Department of Energy to develop modular radiation shielding for microreactors, building on successful Phase I work led by materials scientist Matthew Karnick. The project aims to optimize materials and scale manufacturing for commercialization, with Curtiss-Wright Nuclear as a subcontractor. CPS filed a provisional patent in July 2024 and has explored commercial opportunities, with SBIR funding exceeding $3 million.

© Copyright 2025. All Rights Reserved by MedPath